About this trial
this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.
Eligibility criteria
Qualifiers
Individuals who are diagnosed with Primary Ciliary Dyskinesia OR
Individuals with abnormal PCD diagnostics (abnormal ciliary biopsy or PCD genetics) OR
Individuals with unexplained bronchiectasis OR
Neonatal respiratory distress
Disqualifiers
Individuals who are unable to understand the requirements of the study.
Individuals (or guardians) who are unwilling to provide consent.
Individuals who are unable to complete the testing
Recent history of sinus surgery (within four weeks) or bloody nose (within one week) of testing (they can be included at a later date)
Trial design
Treatments tested in this trial
- Not listed